COBRE Center on Opioids and Overdose (patient-facing summary)
Official title: COBRE Center on Opioids and Overdose
Funded at Rhode Island Hospital · NIH-11406217 · Data updated 2026-11-12
A funded program at Rhode Island Hospital to support researchers studying why people become vulnerable to opioid misuse and overdose, and to develop better ways to prevent and treat them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | September 1, 2018 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $2,112,758 |
| NIH project number | 5P20GM125507-09 |
| Project ID | NIH-11406217 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults affected by opioid use disorder or at risk of overdose who may benefit from new prevention and treatment strategies informed by this research.
✕Less likely to help
Individuals not connected to opioid use or overdose risk or those outside the study infrastructure may not directly benefit.
What this research studies
This center brings together scientists at Rhode Island Hospital and partner institutions to study opioids and overdose. It includes mentoring for junior investigators and services that help turn research into useful policy and practice. Four interdisciplinary cores provide the infrastructure, guidance, and resources needed to advance research and patient impact. The goal is to build a durable group of experts focused on opioids that can improve care for affected communities.
Why it matters
Potential benefit: If successful, the project could lead to better prevention, treatment approaches, and policy guidance to reduce opioid harm.
How similar studies have gone: Previous COBRE programs have shown that structured mentoring and core resources can accelerate translational research in complex conditions like opioid misuse.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Rich, Josiah D — Rhode Island Hospital
- Study coordinator: Rich, Josiah D
Related research
Other NIH-funded projects on the same topics.
-
How often to treat schistosomiasis to protect the liver
A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.
-
Technology-assisted overdose response tools for Rhode Island communities
A Rhode Island hospital-led project will test easy-to-use, tech-enabled tools (like wall buttons, wearable sensors, and a mobile app) to help detect and respond to overdoses in real-world settings.
-
Mindfulness training to lower cardiovascular risk for moms and babies during pregnancy
A mindfulness program is being tested during pregnancy to help prevent high blood pressure and heart problems for mothers and their babies.
-
Point-of-care test to spot risk of liver scarring from Schistosoma japonicum
This project aims to develop a simple clinic test to find people with S. japonicum infection who are likely to develop worsening liver scarring so they can get treatment earlier.
-
Mobile phone-based screening for anemia in young children in western Kenya
A low-cost, phone-based screening approach helps identify anemia in young children in western Kenya so they can get timely care.
-
Role of lactate transporters in lung scarring
Aims to see if blocking lactate transporters can slow or stop scar-forming cells from thickening the lungs in people with fibrotic lung disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.